Aktie A3CWW7 GEMINA LABORATORIES LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Gemina Laboratories Ltd.

Aktien

A3CWW7

CA3686501071

GLAB

Markt geschlossen - Canadian Securities Exchange
Andere Börsenplätze
 17:36:22 02.05.2024 		% 5 Tage % 1. Jan.
0.5 CAD -16.67% Intraday Chart für Gemina Laboratories Ltd. 0.00% -7.41%
02.04. Gemina Laboratories unterzeichnet erstes strategisches Lizenzabkommen CI
2023 Gemina Laboratories Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Oktober 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Gemina Laboratories : Financial Statement Request Form
Gemina Laboratories : Notice of Meeting and Management Information Circular
Gemina Laboratories Sign First Strategic License Agreement
Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding
Gemina Laboratories Ltd. announced that it expects to receive CAD 1 million in funding
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
Gemina Laboratories Ltd. Announces the Resignation of Rob Porter as Director and President
READYGO DIAGNOSTICS INITIATES AN ASSAY DEVELOPMENT CONTRACT WITH GEMINA LABORATORIES FOR THE DETECTION OF DENGUE FROM SALIVA SAMPLES
Gemina Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
Gemina Laboratories : to participate in poster session at AACC scientific meeting
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ANNOUNCE THE FEASIBILITY OF MYCOBACTERIUM TUBERCULOSIS (MTB) DIAGNOSIS IN SALIVA
Gemina Laboratories Ltd. Laboratories and ReadyGo Diagnostics Limited Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023
Gemina Laboratories Ltd. Auditor Raises 'Going Concern' Doubt
Gemina Laboratories Ltd. Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ENTER AN ASSAY DEVELOPMENT AGREEMENT FOR THE RAPID DETECTION OF MYCOBACTERIUM TUBERCULOSIS (MTB)
Gemina Laboratories Ltd. announced that it has received CAD 2.604746 million in funding
Gemina Laboratories Ltd. Announces Board Changes
Gemina Laboratories Ltd. Announces Board Changes
Gemina Laboratories Ltd. Completes Influenza A/B Diagnostic Test Prototype
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CWW7 Aktie
  4. Nachrichten Gemina Laboratories Ltd.
  5. Andere Sprachen